Kennedy pushes regulated peptide marketplace as FDA weighs interim access policy
The FDA has sent an "Interim Access Policy" on peptides to the White House that would let the agency exercise enforcement discretion over certain compounded products.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 21 06:36 ETSource: Newsradio WTAM 1100
The wire
- 01Health Secretary Robert F. Kennedy Jr. said on Fox News on October 20 that the administration wants Americans to be able to buy peptides made in inspected factories, while acknowledging the products are not FDA-approved as safe or effective.
- 02Specialty and compounding pharmacies could gain assurance against enforcement for peptides including BPC-157, covering a market estimated at $2 billion to $3 billion.
- 03FDA scientists have said the peptides lack sufficient study, and the Center for Science in the Public Interest urged the agency to disregard an advisory committee whose members have peptide-business ties; formal rulemaking could take years.
From the source
Read at wtam.iheart.comRFK Jr. Calls For Regulated Peptide Marketplace
Health Secretary Robert F. Kennedy Jr. is advocating for a regulated market for peptides, aiming to expand access to these drugs through a marketplace promoted on social media. During an appearance on Fox News Tuesday (October 20), Kennedy stated that the Trump administration is working to ensure that Americans have access to peptides that are safe and produced in inspected factories. He acknowled
